530
Views
16
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Evidence-Based Selection of Inhaled Corticosteroid for Treatment of Chronic Asthma

, M.D., F.R.C.P.C., F.C.C.P. & , M.D.
Pages 1-12 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anthony D'Urzo. (2007) Mometasone furoate dry-powder inhaler for the control of persistent asthma. Expert Opinion on Pharmacotherapy 8:16, pages 2871-2884.
Read now

Articles from other publishers (15)

Deyu Zhao, Dehui Chen, Ling Li, YingXue Zou, Yunxiao Shang, Chonglin Zhang, Li Zhang, Jiahua Pan, Qiang Chen, Tao Ai & Qian Ni. (2021) CARE: an observational study of adherence to home nebulizer therapy among children with asthma. Therapeutic Advances in Respiratory Disease 15, pages 175346662098639.
Crossref
Nav Persaud. (2018) Essential medicines and the challenges in the Evidence-Based Manifesto. BMJ Evidence-Based Medicine 23:4, pages 123-124.
Crossref
Rafał Pawliczak. (2014) Leczenie przeciwzapalne w astmie. Alergologia Polska - Polish Journal of Allergology 1:1, pages 38-42.
Crossref
S N Avdeev. (2013) THE ROLE OF NEBULIZED BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF BRONCHIAL ASTHMA. Russian Journal of Allergy 10:6, pages 41-50.
Crossref
Anand C. Patel. (2013) Clinical Relevance of Target Identity and Biology: Implications for Drug Discovery and Development. SLAS Discovery 18:10, pages 1164-1185.
Crossref
Karlen E. Luthy, Emilianne Dougall & Renea L. Beckstrand. (2012) Cost-Effective Asthma Treatments for Uninsured or Underinsured Pediatric Patients. The Journal for Nurse Practitioners 8:8, pages 636-642.
Crossref
Volker Briese. 2011. Arzneimittel und Nahrungsergänzungsmittel in Schwangerschaft und Stillzeit. Arzneimittel und Nahrungsergänzungsmittel in Schwangerschaft und Stillzeit 88 95 .
Gabriele Nicolini, Giovanni Cremonesi & Andrea S. Melani. (2010) Inhaled corticosteroid therapy with nebulized beclometasone dipropionate. Pulmonary Pharmacology & Therapeutics 23:3, pages 145-155.
Crossref
Klaus J. Erb, Domnic H. Martyres & Peter Seither. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Miyuki Hori, Takehisa Iwama, Yumiko Asakura, Masafumi Kawanishi, Junji Kamon, Akihiko Hoshino, Shuya Takahashi, Kenzo Takahashi, Shiro Nakaike & Nobutomo Tsuruzoe. (2009) NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects. European Journal of Pharmacology 618:1-3, pages 63-69.
Crossref
Paul D. Robinson & Peter Van Asperen. (2009) Asthma in Childhood. Pediatric Clinics of North America 56:1, pages 191-226.
Crossref
Daniel GonzalezHartmut Derendorf. (2009) Ciclesonide in the Management of Asthma. Clinical Medicine. Therapeutics 1, pages CMT.S2133.
Crossref
Anwar K. Abdullah & Salman Khan. (2008) Relative oral corticosteroid-sparing effect of 7 inhaled corticosteroids in chronic asthma: a meta-analysis. Annals of Allergy, Asthma & Immunology 101:1, pages 74-81.
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:3, pages 284-314.
Crossref
Martina Teichert, Angelie van der Aalst, Hans de Wit, Marcel Stroo & Peter A. G. M. De Smet. (2007) How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?. European Journal of Clinical Pharmacology 63:12, pages 1171-1177.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.